Atlas Trials

AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

Clinical trial NCT05377658 · RECRUITING

Trial details

NCT number
NCT05377658
Sponsor
Henan Cancer Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2022-07-26
Primary completion
2024-12-31
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.